Judy Bruner - Varian Medical Independent Director

Director

Ms. Judy Bruner serves as Independent Director of the Company. She Served Positions at SanDisk Corporationrationration, a global leader in flash memory storage solutions, Executive Vice President, Administration and Chief Financial Officer and Member of Board of Directors .Senior Vice President and Chief Financial Officer, Palm, Inc., a manufacturer of personal digital assistants, She is Vice President, Finance Corporationrationrate Controller, 3Com Corporationrationration, a digital electronics manufacturer Other Current Public Company Board Memberships Brocade Communications Systems, Inc., a technology company specializing in data and storage networking products Applied Materials, Inc., a provider of engineering solutions Rapid7, a security data and analytics solutions provider. since 2016.
Age 61
Tenure 8 years
Phone650 493-4000
Webwww.varian.com
Bruner served as the chief financial officer for SanDisk from 2004 to this year when it was acquired by Western Digital . She also served as senior vice president and chief financial officer for Palm, Inc. from 1999 to 2004. She has held prior management positions in finance and administration with 3Com Corporationrationrationration, Ridge Computers, Inc. and Hewlett Packard Company. Bruner earned an MBA at the University of Santa Clara in 1986 and a BA in Economics at UCLA in 1980. Bruner is also a member of the Board of Directors of Brocade Communications, Inc., where she serves as chair of the audit committee, a member of the Board of Directors of Applied Materials and a member of the board of trustees of the Computer History Museum. She also served in the past on the boards of Vermillion, Inc. and SanDisk Corporationrationrationration, before assuming her executive role there.

Varian Medical Management Efficiency

The company has Return on Asset of 5.92 % which means that on every $100 spent on assets, it made $5.92 of profit. This is considered to be average in the sector. In the same way, it shows a return on shareholders' equity (ROE) of 13.51 %, implying that it generated $13.51 on every 100 dollars invested. Varian Medical's management efficiency ratios could be used to measure how well Varian Medical manages its routine affairs as well as how well it operates its assets and liabilities.
Varian Medical Systems has 350.5 M in debt with debt to equity (D/E) ratio of 0.16, which may show that the company is not taking advantage of profits from borrowing. Varian Medical Systems has a current ratio of 1.48, which is typical for the industry and considered as normal. Note however, debt could still be an excellent tool for Varian to invest in growth at high rates of return.

Similar Executives

Showing other executives

DIRECTOR Age

Miguel CaladoHNI Corp
65
Abbie SmithHNI Corp
67
Pedro CarvalhoBraskem SA Class
N/A
Inge VanwittenberghNyxoah
N/A
Larry PorcellatoHNI Corp
62
Pedro SousaBraskem SA Class
45
Brian SternHNI Corp
71
Cheryl FrancisHNI Corp
67
Mary BellHNI Corp
60
Dhanusha SivajeeHNI Corp
43
Yoseph BornsteinMicrobot Medical
65
Mary JonesHNI Corp
52
Gesner OliveiraBraskem SA Class
63
John HartnettHNI Corp
60
Fabio VenturelliBraskem SA Class
54
Ronald WatersHNI Corp
69
Varian Medical Systems, Inc. designs, manufactures, sells, and services medical devices and software products for treating cancer and other medical conditions worldwide. The company was founded in 1948 and is headquartered in Palo Alto, California. Varian Medical operates under Medical Instruments Supplies classification in the United States and is traded on New York Stock Exchange. It employs 10000 people. Varian Medical Systems (VAR) is traded on New York Stock Exchange in USA and employs 10,000 people.

Management Performance

Varian Medical Systems Leadership Team

Elected by the shareholders, the Varian Medical's board of directors comprises two types of representatives: Varian Medical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Varian. The board's role is to monitor Varian Medical's management team and ensure that shareholders' interests are well served. Varian Medical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Varian Medical's outside directors are responsible for providing unbiased perspectives on the board's policies.
Jeffrey Balser, Independent Director
R Eckert, Independent Chairman of the Board
Regina Dugan, Independent Director
David Illingworth, Independent Director
Judy Bruner, Independent Director
Kolleen Kennedy, Executive Vice President, President - Proton Solutions Division and Chief Growth Officer
J Bruff, Chief Financial Officer, Senior Vice President - Finance
Christopher Toth, President, Chief Executive Officer, Chief Operating Officer
Michael Hutchinson, Senior Vice President, Chief Legal Officer, Corporate Secretary
Anat Ashkenazi, Independent Director
Phillip Febbo, Chief Medical Officer, Director
JeanLuc Butel, Independent Director
Kevin OReilly, Senior Vice President and President Oncology Systems
Chris Toth, President - Varian Oncology Systems
Dow Wilson, President, Chief Executive Officer, Director
Michelle Beau, Independent Director
Francis Facchini, President Interventional Solutions Business

Varian Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Varian Medical a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Pair Trading with Varian Medical

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Varian Medical position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Varian Medical will appreciate offsetting losses from the drop in the long position's value.
The ability to find closely correlated positions to McDonalds could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace McDonalds when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back McDonalds - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling McDonalds to buy it.
The correlation of McDonalds is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as McDonalds moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if McDonalds moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for McDonalds can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.

Other Consideration for investing in Varian Stock

If you are still planning to invest in Varian Medical Systems check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Varian Medical's history and understand the potential risks before investing.
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Fundamental Analysis
View fundamental data based on most recent published financial statements
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Global Correlations
Find global opportunities by holding instruments from different markets
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities